Search results for “Epirubicin” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 308 patents, we discovered top 107 key players by total patent application. Genentech, Inc., Lunan Pharmaceutical Group Co., Ltd., SYNBIAS PHARMA Ltd are dominant in this area. They take 23.70% of the total patent filing.
Genentech, Inc.
California, United States
Patent: 47
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 13
SYNBIAS PHARMA Ltd
Switzerland
Patent: 13
Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 9
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 8
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 6
Predictive Oncology, Inc.
Minnesota, United States
Patent: 6
Clinigen Ltd.
United Kingdom
Patent: 6
Meiji Seika Pharma Co., Ltd.
Tokyo-to, Japan
Patent: 6
AstraZeneca PLC
Cambridgeshire, United Kingdom
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 4 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 4
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 75 patents applied in the last 5 years. We discover 51 most active companies in this area. The fast-growing Genentech, Inc., F. Hoffmann-La Roche Ltd., Lunan Pharmaceutical Group Co., Ltd. take 30.67% of patent filing during this period.
Genentech, Inc.
California, United States
Patent: 10
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 7
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 6
XenTech SAS
France
Patent: 5
AstraZeneca PLC
Cambridgeshire, United Kingdom
Patent: 5
NanoVelos SA
Mazowieckie, Poland
Patent: 4
Soochow University
Jiangsu Sheng, China
Patent: 2
Emory University
Georgia, United States
Patent: 2
The University of Virginia Patent Foundation
United States
Patent: 2
InnoBM Pharmaceutics Co. Ltd.
China
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 75 patents in last 5 years, we discover 42 new entrants. XenTech SAS, AstraZeneca PLC, NanoVelos SA are the most active new entrants in this area.
XenTech SAS
France
Patent: 5
AstraZeneca PLC
Cambridgeshire, United Kingdom
Patent: 5
NanoVelos SA
Mazowieckie, Poland
Patent: 4
Soochow University
Jiangsu Sheng, China
Patent: 2
InnoBM Pharmaceutics Co. Ltd.
China
Patent: 2
AstraZeneca UK Ltd.
Cambridgeshire, United Kingdom
Patent: 2
Henan University
Henan Sheng, China
Patent: 1
Guangxi Normal University
Guangxi Zhuangzu Zizhiqu, China
Patent: 1
Jilin Normal University
Jilin Sheng, China
Patent: 1
Sichuan Huiyu Haiyue Pharmaceutical Technology Co., Ltd.
Sichuan Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 99 patents, we discovered top 38 universities and scientific research institutions by total patent application. Shanghai Institute of Pharmaceutical Industry, University of Tokyo, Emory University are dominant in this area. They take 20.20% of the total patent filing.
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 5
University of Tokyo
Tokyo-to, Japan
Patent: 4
Emory University
Georgia, United States
Patent: 4
Tokyo Institute of Technology
Tokyo-to, Japan
Patent: 4
The University of Chicago
Illinois, United States
Patent: 3
University of Manitoba
Manitoba, Canada
Patent: 2
University of Hong Kong
Hong Kong SAR, China
Patent: 2
Zhejiang University
Zhejiang Sheng, China
Patent: 2
Huazhong University of Science & Technology
Hubei Sheng, China
Patent: 2
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: